Member Info for Vanilla

All those unknown 5p trades I think someone knows something....maybe 5p is the deal hope not was hoping for more like 50p!

I seem to recall they timed their purchase and sales extremely well last time

Thought that was very brief with an abrupt Q&A. So the board has insight from the 70m pipeline to give confidence going forwards. Be nice for them to share some of it but not expecting that will be happening so must be some decent H2 numbers in the final results otherwise they have very rose tinted spectacles.....but we will see really is time for the so called sales people to start closing some deals.

Seemed that way but looks more like the French counterparty has gained about 1m shares at 5.3p that looks to have been a determining factor in moving the sp. Whether this means they are selling them who knows not sure why you would if imminent news on funding would result in a much higher sp. Very much up in the air at present like many here was expecting demand for a working machine to have provided the required boost but the uk market for startups even with world leading technology is dire. Keeping everything crossed for a good outcome now and being hopefully optimistic like the BoD.

The 20 centres might still be very interested but until avo are financially stable through raising funds or strategic partnership I wouldn't expect any commitments. Don't see why the details of these discussions can't be used as part of the negotiations for a takeover which will hopefully contribute to a fair value being achieved.

I don't think the placing shares are being dumped the issue is that having to raise funds in this current climate has resulted in a huge discount. It's actually a positive they are even able to raise funds in this market. It's been said numerous times but if they deliver on the numbers the sp will recover. Everything else other than the court case I wouldn't expect to make much difference.

It was announced in the 4th May RNS regarding the fundraise and will be to approve the issue of the required shares for the placing

It's genuine just checked my email and I also have an invite

Oh yeah I forgot about the good luck which seems to have become one of the most significant factors on AIM so I'm keeping my fingers crossed for a much needed boost in most of my investments!!!

Looks like an investment company to me and have been invested in cpx for a while. Fingers crossed for the summary judgment and following trial in July if it gets that far. End of year results could provide a further boost and will be good to hear from the new CEO with lots of positive news.

That is the other paradox in addition to the current AIM valuation paradox as pointed out by Dr Sinclair. Having spent $16b Siemens would be more than welcome to have an exclusive licensing agreement for £75m upfront payment and royalties on future sales. Not much to outlay to protect their already significant investment in proton therapy.

We hope so and huge benefits over radiotherapy guess we'll know soon how interested the market is. With everything we've been told you'd think the competition would be swarming all over this. A sizeable offer would provide a sense of relief but also put an end to the potential sp growth that could have been achieved through successful commercialisation under the existing ownership. Having said that I'd take 50p a share not sure the BoD would with the millions they have invested.

As always these deals including Continental due to commence in 2024 are great news but probably won't impact the sp until we see the numbers. Due to confidentiality I don't expect to see prior details however brokers forcasts might include a guidance from information they have been given. Otherwise it's a case of waiting for results as proof of orders filtering through to the bottom line. We been told H2 has picked up and we'll find out in the end of year results. If this continues into next years figures commencing 1st July and Continental orders occur in the 1st half of 2024 being H2 cpx financial year then I'd expect a serious pick up in the sp. That's what we've all been hoping for and until we see the numbers a bit more patience required maybe the 2024 half year update will be the break through news who knows.

In 6 months he'll be able to exercise 5m shares at a cost of 65.5k. Every 1p increase in the sp is worth 50k in this 1st tranche. Some people seem to think 20m options is a sign the sp will be stuck at these low levels but the gains available with a sp increasing to between 5 and 10p are not out of touch. If progress is achieved these options won't hold back the sp. I still believe this is a good appointment and ties in well with cpx's transformation into a manufacturing company gaining tier 1 automotive customers leading to a similar move with distribution customers. An experienced person at the helm for this continuing process of transformation is good news all round but we still need the numbers!

Wouldn't be surprised if this is all part of an exit strategy by the BoD and major II's. Perhaps AK also feels everything is set up perfectly now to execute the final part that will require a level of effort that he didn't want to commit the time to but is confident in the outcome to be able to take a backseat a reap the rewards through increased share ownership. It probably wasn't the initial plan but it's taken longer with covid and other areas of business such as litigation and deals like Continental having extended timescales that stepping aside now is right for all concerned. Hope it works out as we all hope and believe and the new CEO enters a rich phase of success so that we also benefit.

I'm sure you'll get a more detailed answer but basically the infringement case remains against Tesla and what it has retained of maxwell. The subsequent sale to UCAP has not affected or impacted this case as yet anyway.

Someone posted this on the other board which I thought was an excellent summary of where we are. Always seems like a waiting game but the timing of this raise under the circumstances has been very damaging.

PC01's suggestion of borrowing money some time ago when rates were rock bottom now looks like very wise words. You can easily see a major II retiring AK in favour of one of their chaps as a result of his poor decision making and having to stump up more cash. If that is the case and things genuinely are recovering these changes could be a good thing........

From the othe board:

After the missed expectations too many to mention , the CEO is probably stepping down in order to facilitate this fundraising

Whilst he is to remain a consultant to CAP-XX , it is interesting to note that he is still putting in £60/- of his own money into new placing shares so as to maintain his 2% shareholding . Being over 60 years old , and of a conservative nature , this is fairly significant , particularly as his last trade in CAP-XX shares was to sell 4.7m shares at 5.5p in August 2021 . Interestingly enough , both the Chairman and another long-term NED , also well over 60 years old , are also putting in £80/- of their own money into new placing shares , which is also significant because these two directors have been receiving shares instead of cash for their services to CAP-XX for a very long time

Another important placee is Canaccord , CAP-XX’s largest shareholder with , as of 2 days ago , 14.8% of the equity . Significantly , Canaccord is more than covering its corner in this placing , and will now be a 18% shareholder

There is little doubt that the above vote of confidence by leading players not only reflects the satisfactory trading background and the potential upside from CAP-XX's new product roadmap , but also a belief that CAP-XX has Tesla/Maxwell by the tail in its patent infringement case due to go to trial in July

On Allenby’s most recent forecasts for the year to June 2023 , CAP-XX’s revenue is expected to be A$4.9m , split A$1.6m in the first-half and A$3.3m in the second-half , and , given there is still 2 months of the second-half remaining , it is encouraging to hear CAP-XX confirm that the second-half recovery is on track . This should mean a second-half EBITDA loss of only A$0.2m against one of A$1m in the first-half . For June 2024 Allenby is forecasting revenue of A$7.9m and a positive EBITDA of A$0.34m . This is supported by an expanding sales pipeline , confirmed at US$71.6m pa in the placing RNS , and up from US$50m pa this time last year

CAP-XX’s post raise market cap is only £9.7m . This level reflects both the massive baggage of disappointment from the last several years but the uncertainty regarding litigation etc . By calendar year end we should hopefully be much the wiser .

This isn't a company with a tin pot piece of garbage product like some AIM companies that have disappeared. It has a built and working worlds first proton linear accelerator costing well over £200m and has a bucket load of patents. I'm sure the operators in this market will sit back and be happy to see a competitor pick this up from the administrator for a few 10 million. It's my opinion and could be completely wrong but on the basis what we have been told and seen in the video presentations is true the business is worth substantially more than what ****ty aim values it. This market allows for some poisonous people to make money in destroying great innovation and technology can't wait to escape.

Agreed perhaps they know this person and have full confidence in their ability to deliver. If it proves to be the case it could result in the sp getting back to a sensible level based on the expected revenue this contract alone will deliver. We've all been waiting for any deal of this kind for ages that have never materialised. If it finally does I would expect a good outcome in the sp so we will find out next year one way or another.

Looks like the placing was fully subscribed and as expected the uk retail offer not. The combination of under performance and this suspect AIM market with funds difficult to raise has resulted in a heavily discounted subscription.
I don't believe the sp reflects the assets of cpx but AIM can be brutal and retail confidence is low at the moment.
Hopefully the H2 increasing sales continues and lth's here recover some losses and maybe some move into profit. I also have a ton of these so did not participate in the retail offer but will not be surprised to see that those who took the opportunity to lower averages or those new investors buying in at this level will soon be sitting on profits while many loyal lth's have a further wait. If you read across other BB's I think you'll find AIM is a dying market for investors and whilst cpx haven't helped themselves they'd be better off somewhere else most probably via a takeover as mentioned already.